Back to Search Start Over

A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.

Authors :
Altea-Manzano P
Doglioni G
Liu Y
Cuadros AM
Nolan E
Fernández-García J
Wu Q
Planque M
Laue KJ
Cidre-Aranaz F
Liu XZ
Marin-Bejar O
Van Elsen J
Vermeire I
Broekaert D
Demeyer S
Spotbeen X
Idkowiak J
Montagne A
Demicco M
Alkan HF
Rabas N
Riera-Domingo C
Richard F
Geukens T
De Schepper M
Leduc S
Hatse S
Lambrechts Y
Kay EJ
Lilla S
Alekseenko A
Geldhof V
Boeckx B
de la Calle Arregui C
Floris G
Swinnen JV
Marine JC
Lambrechts D
Pelechano V
Mazzone M
Zanivan S
Cools J
Wildiers H
Baud V
Grünewald TGP
Ben-David U
Desmedt C
Malanchi I
Fendt SM
Source :
Nature cancer [Nat Cancer] 2023 Mar; Vol. 4 (3), pp. 344-364. Date of Electronic Publication: 2023 Feb 02.
Publication Year :
2023

Abstract

Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver are lipid-rich environments. Moreover, we observe that pre-metastatic niche formation increases palmitate availability only in the lung, whereas a high-fat diet increases it in both organs. In line with this, targeting palmitate processing inhibits breast cancer-derived lung metastasis formation. Mechanistically, breast cancer cells use palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. Concomitantly, lysine acetyltransferase 2a expression is promoted by palmitate, linking the available acetyl-CoA to the acetylation of the nuclear factor-kappaB subunit p65. Deletion of lysine acetyltransferase 2a or carnitine palmitoyltransferase 1a reduces metastasis formation in lean and high-fat diet mice, and lung and liver metastases from patients with breast cancer show coexpression of both proteins. In conclusion, palmitate-rich environments foster metastases growth by increasing p65 acetylation, resulting in a pro-metastatic nuclear factor-kappaB signaling.<br /> (© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.)

Details

Language :
English
ISSN :
2662-1347
Volume :
4
Issue :
3
Database :
MEDLINE
Journal :
Nature cancer
Publication Type :
Academic Journal
Accession number :
36732635
Full Text :
https://doi.org/10.1038/s43018-023-00513-2